303 related articles for article (PubMed ID: 10551668)
1. Treatment of inclusion body myositis.
Cherin P
Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
[TBL] [Abstract][Full Text] [Related]
2. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
[TBL] [Abstract][Full Text] [Related]
3. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.
Askanas V; Engel WK; Bilak M; Alvarez RB; Selkoe DJ
Am J Pathol; 1994 Jan; 144(1):177-87. PubMed ID: 8291607
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory, immune, and viral aspects of inclusion-body myositis.
Dalakas MC
Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
[TBL] [Abstract][Full Text] [Related]
5. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
[TBL] [Abstract][Full Text] [Related]
7. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
Dalakas MC
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
[TBL] [Abstract][Full Text] [Related]
8. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects.
Engel WK; Askanas V
Neurology; 2006 Jan; 66(2 Suppl 1):S20-9. PubMed ID: 16432141
[TBL] [Abstract][Full Text] [Related]
9. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging.
Askanas V; Engel WK
Scand J Rheumatol; 1998; 27(6):389-405. PubMed ID: 9855208
[TBL] [Abstract][Full Text] [Related]
10. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles].
Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G
Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175
[TBL] [Abstract][Full Text] [Related]
11. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
Askanas V; Engel WK
Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
[TBL] [Abstract][Full Text] [Related]
12. [Inclusion body myositis (IBM) -- a review].
Czaplinski A; Renaud S; Fuhr P
Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
[TBL] [Abstract][Full Text] [Related]
13. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
Sarkozi E; Askanas V; Engel WK
Am J Pathol; 1994 Dec; 145(6):1280-4. PubMed ID: 7992832
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
Dalakas MC
Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
[TBL] [Abstract][Full Text] [Related]
15. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
Askanas V; Engel WK
Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
[TBL] [Abstract][Full Text] [Related]
16. Inclusion body myositis (IBM).
Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
[TBL] [Abstract][Full Text] [Related]
17. Inclusion body myositis.
Chou SM
Baillieres Clin Neurol; 1993 Nov; 2(3):557-77. PubMed ID: 8156143
[TBL] [Abstract][Full Text] [Related]
18. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
Askanas V; Engel WK; Nogalska A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
[TBL] [Abstract][Full Text] [Related]
20. Long-term observational study of sporadic inclusion body myositis.
Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D
Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]